Bank of New York Mellon’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,990
| Closed | -$3.67K | – | 4467 |
|
|
2022
Q4 | $3.67K | Hold |
20,990
| – | – | ﹤0.01% | 4454 |
|
|
2022
Q3 | $9K | Hold |
20,990
| – | – | ﹤0.01% | 4513 |
|
|
2022
Q2 | $18K | Sell |
20,990
-126,267
| -86% | -$108K | ﹤0.01% | 4504 |
|
|
2022
Q1 | $811K | Sell |
147,257
-1,003
| -0.7% | -$5.52K | ﹤0.01% | 3437 |
|
|
2021
Q4 | $1.44M | Sell |
148,260
-42,349
| -22% | -$410K | ﹤0.01% | 3176 |
|
|
2021
Q3 | $3.41M | Sell |
190,609
-20,992
| -10% | -$375K | ﹤0.01% | 2690 |
|
|
2021
Q2 | $5.17M | Buy |
211,601
+18,708
| +10% | +$457K | ﹤0.01% | 2468 |
|
|
2021
Q1 | $5.11M | Buy |
192,893
+35,083
| +22% | +$930K | ﹤0.01% | 2438 |
|
|
2020
Q4 | $1.2M | Buy |
157,810
+6,934
| +5% | +$52.6K | ﹤0.01% | 3157 |
|
|
2020
Q3 | $755K | Sell |
150,876
-348
| -0.2% | -$1.74K | ﹤0.01% | 3282 |
|
|
2020
Q2 | $904K | Buy |
151,224
+20,053
| +15% | +$120K | ﹤0.01% | 3163 |
|
|
2020
Q1 | $583K | Sell |
131,171
-8,614
| -6% | -$38.3K | ﹤0.01% | 3277 |
|
|
2019
Q4 | $1.33M | Buy |
139,785
+14,530
| +12% | +$138K | ﹤0.01% | 3084 |
|
|
2019
Q3 | $984K | Buy |
125,255
+3,759
| +3% | +$29.5K | ﹤0.01% | 3187 |
|
|
2019
Q2 | $1.91M | Buy |
121,496
+33,092
| +37% | +$521K | ﹤0.01% | 2815 |
|
|
2019
Q1 | $1.6M | Buy |
88,404
+50,579
| +134% | +$915K | ﹤0.01% | 2901 |
|
|
2018
Q4 | $609K | Buy |
37,825
+8,357
| +28% | +$135K | ﹤0.01% | 3378 |
|
|
2018
Q3 | $707K | Buy |
+29,468
| New | +$707K | ﹤0.01% | 3458 |
|